KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biogen (BIIB) Other financing activities (2016 - 2025)

Historic Other financing activities for Biogen (BIIB) over the last 17 years, with Q4 2025 value amounting to -$1.3 million.

  • Biogen's Other financing activities fell 12954.55% to -$1.3 million in Q4 2025 from the same period last year, while for Dec 2025 it was $5.0 million, marking a year-over-year increase of 32727.27%. This contributed to the annual value of $5.0 million for FY2025, which is 32727.27% up from last year.
  • Per Biogen's latest filing, its Other financing activities stood at -$1.3 million for Q4 2025, which was down 12954.55% from $6.2 million recorded in Q3 2025.
  • In the past 5 years, Biogen's Other financing activities registered a high of $16.5 million during Q1 2023, and its lowest value of -$106.2 million during Q2 2021.
  • Moreover, its 5-year median value for Other financing activities was $1.3 million (2025), whereas its average is -$3.5 million.
  • In the last 5 years, Biogen's Other financing activities tumbled by 83241.38% in 2021 and then skyrocketed by 395000.0% in 2023.
  • Over the past 5 years, Biogen's Other financing activities (Quarter) stood at $400000.0 in 2021, then tumbled by 50.0% to $200000.0 in 2022, then skyrocketed by 3950.0% to $8.1 million in 2023, then tumbled by 45.68% to $4.4 million in 2024, then plummeted by 129.55% to -$1.3 million in 2025.
  • Its Other financing activities stands at -$1.3 million for Q4 2025, versus $6.2 million for Q3 2025 and -$1.2 million for Q2 2025.